The additional profiling of other sialyltransferase genes, ST6GAL2, ST3GAL4 and ST3GAL5, was found to display varying gene expression levels between both cancer tissue types (Fig. 6B) and across all tested ovarian cancer cell lines (Fig. 6D). This evidence concerns the gene ST6GAL2 and ovarian carcinoma.